These findings not only establish B. mori as an efficient bioreactor for large-scale NT-3 production but also reveal a dual function of NT-3 for the preservation of bioactivity and programmable release kinetics, which makes it a promising candidate for treating peripheral neuropathies and spinal cord injuries. Here, NTF3 is linked to peripheral neuropathy.